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Prevalence and Severity of Periodontitis
in Indonesian Patients With
Rheumatoid Arthritis
Hendri Susanto,* Willem Nesse,† Nyoman Kertia,‡ Juwono Soeroso,§ Yvonne Huijser van Reenen,i
Eveliene Hoedemaker,i Dewi Agustina,* Arjan Vissink,† Frank Abbas,i and Pieter U. Dijkstra†¶#
Background: Patients with rheumatoid arthritis (RA) may have more prevalent and severe periodontitis
than healthy controls. Periodontitis may increase the systemic inflammation in RA. The aim of this study
is to assess periodontitis prevalence and severity and its potential association with systemic inflamma-
tion in Indonesian patients with RA.
Methods: A full-mouth periodontal examination including probing depth, gingival recession, plaque
index, and bleeding on probing was performed in 75 Indonesians with RA and 75 age-, sex-, and smok-
ing-matched Indonesian controls. A validated questionnaire was used to assess smoking, body mass
index, education, and medical conditions. In addition, in all participants, the use of drugs was noted,
and erythrocyte sedimentation rates and serum levels of high-sensitivity C-reactive protein (hsCRP),
rheumatoid factor, and anti-citrullinated protein antibodies were measured. Differences in periodontitis
prevalence and 12 measures of periodontitis severity between patients with RA and controls were
analyzed using univariate analyses.
Results: No significant differences in periodontitis prevalence and 11 measures of periodontitis se-
verity between patients with RA and controls were observed. Conversely, patients with RA had a signifi-
cantly lower surface area of healthy pocket epithelium versus controls (P = 0.008), and a tendency
toward higher hsCRP levels was observed in patients with RA with severe periodontitis compared with
patients with RA with no mild or moderate periodontitis (P = 0.063). It has to be noted that all patients
with RA were on anti-inflammatory drugs, whereas none of the controls used such drugs.
Conclusion: Prevalence and severity of periodontitis in Indonesian patients with RA is comparable to
controls but with less healthy pocket epithelium than in controls and a tendency toward a higher inflam-
matory state in patients with RA and severe periodontitis. J Periodontol 2013;84:1067-1074.
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R
heumatoid arthritis (RA) is an autoimmune
disease characterized by symmetric inflam-
mation of mainly hand and wrist joints, which
leads to permanent deformity and breakdown of
these joints.1 RA impairs quality of life and is asso-
ciated with early mortality. The cause of RA is still
unknown.
Studies in Australia, America, Europe, and Africa
have shown that patients with RA have more prev-
alent and severe periodontitis than non-RA controls
when controlling for important confounders, such
as dental plaque, age, sex, and smoking.2-9 However,
studies in Sweden, Brazil, the United States, Turkey,
and Japan did not find a higher prevalence and
severity of periodontitis in patients with RA.10-14 In
other words, the prevalence and severity of peri-
odontitis in patients with RA may be influenced by
genetic, dietary, cultural, and other differences as-
sociated with differences in nationality and ethnicity.
Although white, African-American, Latin-American,
North African, and Japanese populations have been
studied,2-8,11 no study has yet been performed in a
Southeast Asian population. Furthermore, the use
of non-steroidal anti-inflammatory drugs (NSAIDs)
and rheumatoid agents in patients with RA may affect
the proinflammatory and anti-inflammatory cytokine
levels in patients with RA and thus confound the
association between RA and periodontitis.15,16
In addition to differences in results attributable
to variations in nationality and ethnicity, the asso-
ciation between RA and periodontitis may also differ
because a variety of definitions for periodontitis
prevalence and severity have been used. Although
various studies have assessed the association be-
tween periodontitis and RA,2-16 no study has yet
investigated the effect of using several definitions
for periodontitis prevalence and severity on the as-
sociation between periodontitis and RA.
Recently, some pilot-intervention studies have
pointed toward periodontitis as a risk factor for
RA.17-20 After treating periodontitis, a reduction in
RA disease activity was shown, possibly related to a
reduction in periodontitis-associated inflammatory
burden. Periodontitis poses an inflammatory burden,
as evidenced by increased levels of erythrocyte
sedimentation rate (ESR) and C-reactive protein
(CRP) in patients with RA with periodontitis.2-5 Thus,
periodontitis may increase systemic inflammation,
which may in turn lead to increased RA severity.21
Likewise Helicobacter pylori infections may con-
tribute to increased RA severity by posing inflam-
matory burden, whereas eradication of this bacterium
in patients with RA improves the clinical condition
and laboratory markers of RA disease activity.22
Thus, the aims of this study are to compare
periodontitis prevalence and periodontitis severity
in Indonesian patients with RA with Indonesian
age-, sex-, and smoking-matched controls, using a
variety of definitions for periodontitis severity.23 In
addition, whether inflammatory burden differed be-
tween participants with or without periodontitis was
analyzed, for both patients with RA and controls.
MATERIALS AND METHODS
From July 2008 to February 2009, all consecutive
patients with RA visiting the Internal Medicine De-
partment of the Dr. Sardjito Hospital, Yogyakarta,
Indonesia; the Clinic for Rheumatology of PKU
Muhammadiyah Hospital, Yogyakarta, Indonesia; or
a private rheumatology clinic in Surabaya, Indonesia,
that matched the inclusion criteria were informed
about the nature of the study and asked to partici-
pate. All patients with RA had been diagnosed by
rheumatologists (NK and JS) according to revised
American College of Rheumatology 1987 criteria1
and were on a regular recall schedule for RA. During
the same period, age-, sex-, and smoking-matched
controls were recruited from the consecutive patients
that visited the Prof. Soedomo Dental Hospital,
Faculty of Dentistry Gadjah Mada University, Yo-
gyakarta, Indonesia, for their routine dental checkup.
Likewise, these controls were informed about the
nature of the study and asked to participate. The
inclusion criteria for patients with RA and controls
were: 1) ‡18 years old and 2) ‡8 remaining teeth.
The criterion of eight remaining teeth was chosen
because there should at least be a minimum peri-
odontitis-associated inflammatory burden, given
that this inflammatory burden decreases with de-
creasing number of teeth (e.g., edentulous patients
do not have any periodontitis-associated inflam-
matory burden). Exclusion criteria were: 1) presence
of other systemic diseases or conditions (e.g., di-
abetes) that are known as risk factors for peri-
odontitis and 2) a history of treatment for periodontal
disease. With regard to controls, additional exclusion
criteria were the use of medication or consuming
drugs that are known to be risk factors for peri-
odontitis.15,16 Because no (pilot) data concerning
differences between Indonesian patients with RA and
controls were available, a formal power analysis was
not performed. Each patient with RA wasmatched with
one control. This study was approved by the Ethical
Committee for Research of the Medical Faculty of
GadjahMadaUniversity. Both oral andwritten informed
consent were obtained from all patients and controls.
All participants completed a validated general
health assessment questionnaire to assess the pres-
ence of other diseases and the use of medication.
This questionnaire was composed of questions as-
sessing symptoms related to systemic diseases,
such as heart disease, pulmonary disease, endocrine
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disorders, hematologic disease, gastrointestinal dis-
orders, genitourinary disorders and neurologic dis-
ease, and the use of medications.24 Information
about age, sex, smoking (current and pack years),
education level, and body mass index (BMI) was
obtained by means of a questionnaire.
All participants underwent a full-mouth peri-
odontal examination on six sites per tooth assessing
probing depth (PD), gingival recession (GR), plaque
index (PI), bleeding on probing (BOP), and clinical
attachment loss (AL). All permanent fully erupted
teeth were examined with a manual periodontal
color-coded standard probe.** Measurements were
made in millimeters and were rounded to the nearest
whole millimeter. BOP was recorded as either present
or absent within 30 seconds of probing. PI was defined
as being present or absent at six points on each tooth.2
The number of missing teeth was also recorded.
Periodontitis prevalence was established accord-
ing to Page and Eke23 case definitions. Periodonti-
tis severity was operationalized using a variety of
methods (number of sites with PD ‡4, ‡5, and
‡6 mm; number of sites with AL ‡3, ‡4, ‡5, and
‡6 mm; mean PD; mean AL; and percentage of sites
with BOP anywhere in the dentition), which are all
currently used to study the association between
periodontitis and other diseases.25-27 To facilitate
calculation, a freely accessible spreadsheet†† was
used online.28 Furthermore, two recently introduced
measures of periodontitis severity, the periodontal
epithelial surface area (PESA) and the periodontal
inflamed surface area (PISA),29 were calculated,
again using the same spreadsheet.28 PESA reflects
the surface area of all pocket epithelium in square
millimeters, whereas PISA reflects the surface area
of bleeding pocket epithelium in square millimeters.
PESA and PISA were calculated using conventional
AL, GR, and BOP measurements. PISA quantifies
the surface area of inflamed periodontal tissue in
square millimeters and is a measure of inflammatory
burden posed by periodontitis.26,29
Finally, a blood sample via vena puncture was
taken from all participants (patients with RA and
controls) to determine CRP, ESR, rheumatoid factor
(RF), and anti-citrullinated protein antibody (ACPA).
High-sensitivity CRP (hsCRP) was determined by
chemiluminescent enzyme immunoassay.‡‡ ESR
was determined by the Westergren method, RF was
determined by latex agglutination methods, and
ACPA was determined by an enzyme-linked immu-
nosorbent assay.§§
Data are presented as mean and standard deviation
in case of normal distribution, medians and inter-
quartile range (IQR) in case of non-normal distribu-
tion, and percentages for categorical data. Because
patients with RA and controls were matched (age, sex,
and smoking), differences between patients with RA
and controls were analyzed using paired-sample t
test or, in case of a non-normal distribution, Wilcoxon
signed-rank test and McNemar test. Differences be-
tween periodontal status groups within patients with
RA and controls were analyzed using Kruskal-Wallis
(for medians) and x2 (for percentages) tests, with
linear-by-linear association. In case of lack of ex-
pected cell count, the exact method was used. Sta-
tistics were calculated using statistical software.ii
RESULTS
Prevalence and Severity of Periodontitis in
Patients With RA and Controls
In total, 75 patients with RA (median disease dura-
tion of 4 years; IQR = 2.0; 6.0 range; 1 to 15 years)
and 75 age-, sex-, and smoking-matched controls
were included. All consecutive patients with RA
and controls that fulfilled the inclusion criteria du-
ring the recruiting period agreed to participate in
this study. The characteristics of patients with RA
and controls, including level of education, origin,
BMI, and medication use, are summarized in Table 1.
Level of education and origin were comparable
between patients with RA and controls. Mean age,
BMI, and number of teeth of patients with RA were
significantly lower than controls, whereas PI was sig-
nificantly higher. None of the controls usedmedication
other than birth control pills or antihypertensives.
Prevalence and severity of periodontitis were com-
parable between patients with RA and control in-
dividuals, but the surface of healthy pocket epithelium
(PESA) was significantly smaller in patients with RA.
Serum Laboratory Markers in Patients With RA
and Controls According to Periodontal Status
Patients with RA and severe periodontitis had a
significantly lower PI and tended to be older than
patients with RA and no, mild, or moderate peri-
odontitis. There was a tendency toward higher hsCRP
levels in patients with RA and severe periodontitis.
Low education level was more common among pa-
tients with RA and severe periodontitis (Table 2; only
the percentage of patients with a low education level
was added to this table, as about half or more of the
participating patients had a low level as opposed to
medium or high). None of the abovementioned dif-
ferences or tendencies was found in controls (Table 3).
DISCUSSION
The prevalence of moderate-to-severe periodontitis
in patients with RA in the current study is fairly high
** Dentsply International, London, UK.
†† Excel 2003 for Windows, Microsoft, Redmond, WA.
‡‡ Immulite 2000, Diagnostic Products, Los Angeles, CA.
§§ ELISA, Euroimmun Medizinische Labordiagnostika, Lu¨beck, Germany.
ii PASW v.18.0, IBM SPSS, Armonk, NY.
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(71%) but similar to those reported in other studies.2,8
However, the prevalence of moderate-to-severe
periodontitis in controls was also high (69%) and not
significantly different. Likewise, some other studies
reported no significant differences in periodontitis
prevalence between patients with RA and con-
trols,10-14 which also might be (partially) attributable
to the potent anti-inflammatory medications used
by the patients with RA.15,16 The vast majority of
studies did find a higher prevalence of periodontitis
in patients with RA compared with controls.2,6-8 It
has to be noted that the patients in these studies, like
Table 1.
Characteristics of and Differences Between Patients With RA and Controls
Characteristic Patients With RA (n = 75) Controls (n = 75) Mean Difference (SD) P
Females, n (%) 60 (80) 60 (80)
Smokers, n (%) 5 (7) 5 (7)
Age (years), mean (SD) 46.5 (11.3) 46.9 (11.2) 0.4 (1.3) 0.015*
Education (low), n (%) 45 (60) 43 (57) 0.868†
Java origin (yes), n (%) 63 (84) 65 (87) 0.815†
BMI (kg/m2), mean (SD) 22.5 (3.7) 24.1(3.6) 1.6 (5.0) 0.005*
PI (%), median (IQR) 97 (94; 99) 95 (90; 98) 0.023‡
Number of teeth, median (IQR) 26 (22; 29) 28 (25; 29) 0.034‡
Periodontitis severity, median (IQR)
PESA (mm2) 825.0 (676.1; 944.3) 892.1 (786.4; 1,040.1) 0.008‡
PISA (mm2) 98.7 (43.2; 179.4) 98.6 (35.3; 221.6) 0.669‡
Number of sites
AL ‡3, median (IQR) 22 (9; 44) 32 (14; 54) 0.099‡
AL ‡4, median (IQR) 5 (1; 18) 4 (1; 17) 0.998‡
AL ‡5, median (IQR) 0 (1; 6) 0 (0; 4) 0.666‡
AL ‡6, median (IQR) 0 (0; 2) 0 (0; 1) 0.890‡
PD ‡4, median (IQR) 1 (0; 5) 2 (0; 6) 0.638‡
PD ‡5, median (IQR) 0 (0; 1) 0 (0; 1) 0.734‡
PD ‡6, median (IQR) 0 (0; 0) 0 (0; 0) 0.963‡
BOP, median (IQR) 11 (6; 21) 10 (4; 25) 0.951‡
PD (mm), mean (SD) 1.7 (0.4) 1.8 (0.4) 0.1 (0.6) 0.205‡
AL (mm), mean (SD) 2.0 (0.8) 2.1 (0.8) 0.0 (1.1) 0.930‡
Periodontitis prevalence,§ n (%) 0.547‡
No/mild 22 (29) 23 (31)
Moderate 37 (49) 40 (53)
Severe 16 (21) 12 (16)
Biomarkers, median (IQR)
ACPA IgG (RU/mL) 1.2 (0.0; 46.2) 0.0 (0.0; 0.0) <0.001‡
ESR (mm/hour) 36 (18; 53) 22 (13; 35) 0.001‡
hsCRP (mg/L) 4.8 (1.7; 17.1) 1.1 (0.6; 2.9) <0.001‡
Medication, n (%)
Corticosteroid (prednisolone) 60 (80) 0 (0)
NSAIDs 55 (73) 0 (0)
Methotrexate 52 (69) 0 (0)
Chloroquine 36 (48) 0 (0)
Leflunomide 7 (9) 0 (0)
Sulfasalazine 6 (8) 0 (0)
Antihypertensives 5 (7) 6 (8)
Birth control pills 0 1 (1)
IgG = immunoglobulin G; RU = relative units.
Data were analyzed pairwise.
* Paired t test.
† McNemar test.
‡ Wilcoxon signed-rank test.
§ Criteria of Page and Eke.23
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in the present study, were taking anti-in-
flammatory drugs. Furthermore, an associa-
tion between periodontitis and RA also has
been shown in animal studies.30,31 Both hu-
man and animal studies point toward an as-
sociation between periodontitis and RA that
might be attributable to sharing similar in-
flammatory markers, namely, increased cy-
tokines, matrix metalloproteinases (MMPs),
and CRPs.32,33 This association is also in line
with results from animal studies, showing that
induction of arthritis in rats resulted in an
increased periodontal breakdown and that
expression of an endogenous inhibitor of host-
derived MMPs, namely, tissue inhibitor of
MMPs (TIMPs), reduces the severity of peri-
odontitis. Also in human studies, such a pos-
sible beneficial effect of TIMPs is shown.34,35
For example, O’Dell et al.34 showed that
systemic administration of a TIMP (sub-
antimicrobial-dose doxycycline), Food and
Drug Administration–approved for peri-
odontitis, reduced the severity of RA in these
patients. Administration of this TIMP to pa-
tients with severe cardiovascular disease was
found to significantly reduce CRP, interleukin-
6 (IL-6), and MMP-9 in peripheral blood.35
Given the abovementioned, the findings
of the present study might well be explained
by the use of potent anti-inflammatory med-
ication in patients with RA. RA and chronic
and aggressive periodontitis are chronic in-
flammatory disorders characterized by de-
regulation of the host inflammatory response.
Increased secretion of proinflammatory me-
diators results in soft and hard tissue break-
down of the synovium and periodontium,
respectively. Both diseases share risk factors
and have pathologic pathways in common,
resulting in loss of function and disability as
a final clinical outcome.36 As such, drugs used
for RA have also been reported to reduce
periodontitis severity.11,15,16 Approximately
80% of the patients with RA in the present
study are on corticosteroids (Table 1). Corti-
costeroids have anti-inflammatory activities
by inhibiting proinflammatory proteins, such
as cyclooxygenase 2, IL-1, IL-2, and IL-6,
tumor necrosis factor alpha, and adhesion
molecules.37 Approximately three quarters of
patients with RA in the present study used
NSAIDs, which have anti-inflammatory ac-
tivity inhibiting cyclooxygenase, an enzyme
that catalyzes the conversion of arachidonic
acid to prostaglandins and thromboxanes.



































































































































































































































































































































































































































































































































































































































































































































































































J Periodontol • August 2013 Susanto, Nesse, Kertia, et al.
1071
alveolar bone loss in periodontitis.38 A high
number of patients with RA (Table 1) also used
disease-modifying antirheumatoid drugs, such as
methotrexate, sulfasalazine, chloroquine, and le-
flunomide. These drugs are taken to reduce the
inflammatory component in RA. Methotrexate in
combination with prednisolone decreases blood
levels of IL-1b and IL-6 and inhibits the intensity of
free radical–mediated processes in RA,39 which
also may decrease periodontal inflammation.
Although the PISA was comparable between
patients with RA and controls (Table 1), PESA was
significantly lower in patients with RA, pointing
toward more severe periodontitis in patients with
RA. Furthermore, the fact that there is not a sig-
nificant difference between prevalence of peri-
odontitis between patients with RA and controls
also might be attributable to the remarkably high
periodontitis prevalence in the Indonesian con-
trols of this study. This is not surprising because
the prevalence of periodontitis in the Indonesian
general population may, depending on the defi-
nition used, be as high as 80%.40
BMI may also have obscured an association
between periodontitis and RA. Ideally, controls
should also have been matched for BMI because
fat tissue may cause a chronic, low-grade sys-
temic inflammatory response that influences the
level of CRP.41 However, the randomly selected
controls had, on average, a higher BMI. The higher
BMI of controls compared with patients with RA
has been reported previously in a study that failed
to show BMI as a significant predictor of peri-
odontitis in patients with RA.8 In another study42
BMI was statistically associated with missing
teeth, PD, and PI but again not with AL, gingival
index, or periodontitis.
Noteworthy is the fact that there was a ten-
dency toward higher hsCRP levels in patients with
RA and moderate-to-severe periodontitis com-
pared with those with no/mild periodontitis (Table
2). Other studies also found higher levels of hsCRP
in patients with RA and periodontitis.2,7 No sig-
nificant difference in hsCRP was observed be-
tween controls with periodontitis and controls
without periodontitis (Table 3). Two main expla-
nations can be given for these findings. First,
periodontitis may aggravate RA because peri-
odontitis is accompanied by higher CRP
levels.43-47 The elevation of inflammatory cyto-
kines (such as IL-1 and IL-6) that are locally in-
duced by periodontitis48 is thought to induce
systemic inflammation by increasing serum CRP
levels and thus to contribute to an increased
systemic inflammation in RA.49 Second, RA may
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is also accompanied by higher CRP levels,49,50 higher
CRP levels may be a reflection of active RA, which
may contribute to an increased inflammatory state in
periodontitis. Interestingly, CRP level reduces in pa-
tients with RA after periodontal therapy,20 lending
support to the hypothesis that periodontitis may con-
tribute to an increased systemic inflammation in RA.
Another explanation of higher CRP levels in pa-
tients with RA and moderate-to-severe periodontitis
compared with patients with RA and no/mild peri-
odontitis may be confounding by impaired mainte-
nance of oral hygiene, smoking, and low education
level. Regarding oral hygiene, RA affects the wrist
joint and the small joints of the hand. The joint af-
flictions may impair motor function of the hand and
as a result may impair proper oral hygiene mainte-
nance, resulting in periodontitis.51 However, patients
with RA and moderate-to-severe periodontitis had
lower mean PI than patients with RA and no/mild
periodontitis (Table 2). Therefore, impaired main-
tenance of oral hygiene in patients with RA has
probably not confounded the association between
periodontitis and higher hsCRP levels.
CONCLUSIONS
Prevalence and severity of periodontitis in Indonesian
patients with RA is comparable to controls but with
less healthy pocket epithelium than in controls and
a tendency toward a higher inflammatory state in
patients with RA and severe periodontitis. Future
research should focus on whether periodontitis con-
tributes to the increased inflammatory state observed
in patients with RA and periodontitis and whether
periodontitis thereby contributes to increased se-
verity of RA.
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